Dermatology · Havre de Grace, MD
NPI
1578722856
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
930 Revolution St
Havre de Grace, MD, 21078
Phone (410) 939-0961
Groups this clinician bills Medicare through
Medicare paid, 2024
$576K
7,825 services
Medicare patients, 2024
1,829
Average age 75
Drug cost, 2024
$2.7M
2,890 prescriptions
Company payments, 2025
$6,553
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicole J Bright was code 17003 (destruction skin lesion), 2,530 times for 452 patients. In total Nicole J Bright billed 7,825 services in 79 codes, and Medicare paid $576K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,530 | 452 | $5.33 | $13K |
| 99213 Office E&M - Established | Office | 1,568 | 1,104 | $67.63 | $106K |
| 17000 Destruction Skin Lesion | Office | 780 | 611 | $45.98 | $36K |
| 99212 Office E&M - Established | Office | 600 | 440 | $42.76 | $26K |
| 11102 Skin Biopsy | Office | 574 | 507 | $76.28 | $44K |
| 99203 Office E&M - New | Office | 299 | 299 | $83.34 | $25K |
| 17311 Mohs Surgery | Office | 236 | 194 | $534.86 | $126K |
| 11103 Skin Biopsy | Office | 182 | 131 | $40.30 | $7,334 |
| 13121 Wound Repair - All Levels | Office | 90 | 83 | $231.40 | $21K |
| 99202 Office E&M - New | Office | 80 | 80 | $51.93 | $4,154 |
| 17312 Mohs Surgery | Office | 77 | 60 | $343.11 | $26K |
| 17110 Destruction Skin Lesion | Office | 75 | 66 | $90.22 | $6,766 |
| 13132 Wound Repair - All Levels | Office | 58 | 54 | $204.98 | $12K |
| 11602 Skin Lesion Excision | Office | 54 | 50 | $103.47 | $5,587 |
| 17313 Mohs Surgery | Office | 51 | 45 | $507.71 | $26K |
By year: 2022 $622K for 7,556 services; 2023 $502K for 6,978 services; 2024 $576K for 7,825 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicole J Bright prescribed most often to Medicare patients was Mometasone Furoate, with 350 prescriptions and refills. In total Nicole J Bright wrote 2,890 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mometasone Furoate Generic | 350 | 366 | 182 | $7,478 |
| Ketoconazole Generic | 302 | 312 | 147 | $5,670 |
| Mupirocin Generic | 254 | 257 | 193 | $2,038 |
| Triamcinolone Acetonide Generic | 219 | 265 | 138 | $3,583 |
| Betamethasone Dipropionate Generic | 136 | 149 | 75 | $7,011 |
| Clobetasol Propionate Generic | 129 | 144 | 55 | $9,650 |
| Cephalexin Generic | 98 | 102 | 75 | $1,330 |
| Dupixent Pen Dupilumab | 95 | 111 | 19 | $412K |
| Gentamicin Sulfate Generic | 88 | 88 | 66 | $3,573 |
| Doxycycline Hyclate Generic | 79 | 90 | 51 | $1,315 |
| Hydrocortisone Generic | 63 | 67 | 43 | $894 |
| Clindamycin Phosphate Generic | 61 | 61 | 27 | $2,041 |
| Metronidazole Generic | 53 | 55 | 27 | $2,618 |
| Otezla Apremilast | 45 | 47 | Under 11 | $222K |
| Fluorouracil Generic | 42 | 42 | 37 | $2,816 |
Brand drugs: 519 claims; generic drugs: 2,371 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicole J Bright $6,553 ($6,553 in general payments such as food, travel and fees) from 20 companies. The largest payer was Genzyme Corporation with $3,491.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 15 | $3,491 |
| LEO Pharma Inc. | 36 | $550 |
| UCB, Inc. UCB.BR | 33 | $460 |
| Janssen Biotech, Inc. JNJ | 13 | $382 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 12 | $299 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $245 |
| Abbvie Inc. ABBV | 14 | $180 |
| Incyte Corporation INCY | 10 | $159 |
| Galderma Laboratories, L.P. GALD.SW | 14 | $157 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.